S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

China AI Stocks Rally as Regulator Pledges Listing Reforms

A 13% surge in Cambricon Technology shares led a broad rally across China’s AI sector on Thursday, following a pledge from the country’s top securities regulator to accelerate public listings for high-tech firms. The announcement signals a shift toward easing capital market access for developers of large language models.

China AI Stocks Rally as Regulator Pledges Listing Reforms

Wu Qing, chairman of the China Securities Regulatory Commission, outlined these reforms at the Lujiazui forum in Shanghai. The strategy focuses on streamlining listing requirements for the STAR Board and the ChiNext exchange, specifically targeting startups in quantum technology, bio-manufacturing, and embodied intelligence. Beyond the AI sector, the regulator intends to bolster support for companies in modern services and new consumption categories.

This policy pivot aligns with Beijing’s broader push for technological self-sufficiency. By prioritizing "new productive forces," the government aims to catalyze domestic innovation in advanced manufacturing and biotech to offset global supply chain pressures. Alongside these domestic reforms, Wu encouraged eligible Hong Kong-listed companies to pursue dual listings on the mainland. Following the news, the ChiNext Price Index briefly touched a record high before settling with a 1.4% gain at midday, while Moore Threads and MetaX saw significant upward movement.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!